AUS
NZ
UK
CA
USA
IND
Alicanto Minerals Limited (ASX:AQI) has requested the quotation of 183,231 new fully paid ordinary shares on the ASX, issued on 1 July 2026 as partial consideration for acquiring exploration tenements E63/1894 and E63/2216 in Western Australia. These shares were issued at a deemed value of about $1.3644 each and relate to a transaction initially disclosed in May 2026. An additional tranche of shares valued at A$100,000 is pending, contingent on a regulatory exemption for one of the tenements, keeping market focus on the outcome of that approval process.<\/p> <\/div>
Key Points<\/h3>
- Company: Alicanto Minerals Limited (ASX:AQI)<\/li>
- 183,231 new fully paid ordinary shares applied for quotation, issued 1 July 2026<\/li>
- Shares issued as part of consideration for acquiring tenements E63/1894 and E63/2216<\/li>
- Deemed issue price approximately $1.3644 per share for these securities<\/li>
- An additional A$100,000 worth of shares to be issued contingent on a minimum expenditure exemption for E63/1894 from the Department of Mines, Petroleum and Exploration<\/li>
- Total quoted ordinary shares after this quotation: 185,597,924<\/li>
- Investors should monitor the regulatory exemption decision for E63/1894 and further updates on the tenement acquisition<\/li>
<\/ul>
<\/div>
Alicanto Minerals Advances Tenement Acquisition with Share Issue for E63/1894 and E63/2216<\/h2>
Alicanto Minerals Limited has progressed its acquisition of two Western Australian exploration tenements by issuing 183,231 new fully paid ordinary shares as non-cash consideration. The company’s update lodged with the ASX on 1 July 2026 confirms the shares were issued on that date, representing part of the total consideration disclosed in an Appendix 3B filed on 14 May 2026.<\/p>
The tenements involved, E63/1894 and E63/2216, are exploration licences in Western Australia. The share-based payment structure is typical in junior mining deals where conserving cash is important. By issuing shares instead of cash, Alicanto Minerals maintains liquidity while giving the vendor an interest in the company’s future performance. The update did not provide further detail on the financial terms beyond the per-share deemed value.<\/p>
Deemed Share Value of $1.3644 Reflects Non-Cash Consideration<\/h2>
The quotation application describes the 183,231 shares as "part consideration for the acquisition of E63/1894 and E63/2216," with an estimated value of $1.3644 per share. This figure represents the deemed value assigned to the shares at issuance and does not necessarily match the market trading price of AQI shares at quotation.<\/p>
While the company did not specify the total implied value of this tranche, multiplying the number of shares by the deemed price suggests a value near $250,000. Investors should note this is an approximate calculation based on disclosed data rather than a stated figure.<\/p>
Additional A$100,000 Share Tranche Dependent on Regulatory Exemption for E63/1894<\/h2>
The transaction includes a deferred component of A$100,000 in shares, contingent on E63/1894 receiving a minimum expenditure exemption from the Department of Mines, Petroleum and Exploration for the 2026 tenement year.<\/p>
The pricing of this tranche will be based on the 10-day volume-weighted average price (VWAP) of AQI shares at the time of issue, protecting both parties from short-term share price volatility and aligning the consideration with market conditions. Until the exemption is granted or denied, this portion remains outstanding and the acquisition is not fully complete. Investors should watch for updates on the exemption application.<\/p>
Total Quoted Shares Increase to 185,597,924 Following Share Issue<\/h2>
After quoting the 183,231 new shares, Alicanto Minerals’ total quoted fully paid ordinary shares rose to 185,597,924. This figure, generated by the ASX system, may not reflect the current issued capital if other related filings are in process.<\/p>
The new shares represent less than 0.1% of the total post-issue share count, indicating a minimal dilution effect. Investors should also consider the company’s broader capital structure, which includes a significant number of unquoted securities that could impact future dilution.<\/p>
Unquoted Securities Include Over 63 Million Performance Rights<\/h2>
The update reveals Alicanto Minerals holds 63,779,571 performance rights under the code AQIAAK and 1,250,000 options expiring 28 February 2028 with an exercise price of $0.696 per share, listed as AQIAAM.<\/p>
The performance rights represent a substantial potential increase in shares if vested, though the update does not detail their vesting conditions. The options allow exercise only if the AQI share price exceeds $0.696 before expiry.<\/p>
Transaction Timeline: From May 2026 Disclosure to July 2026 Share Quotation<\/h2>
The acquisition process began with an Appendix 3B lodged on 14 May 2026, indicating a proposed securities issue. The 1 July 2026 quotation application confirms the first tranche has now been issued and quoted.<\/p>
The roughly six-week period between disclosure and quotation is typical for non-cash consideration deals, which require due diligence, pricing agreement, and condition satisfaction. The timeline for the deferred tranche depends on the Department of Mines, Petroleum and Exploration’s regulatory review.<\/p>
Western Australian Tenements E63/1894 and E63/2216 Now Part of Alicanto’s Holdings<\/h2>
Tenements E63/1894 and E63/2216, located in the Kalgoorlie Minerals House administrative region, are the focus of this acquisition. Specific details on location, size, or target commodities were not provided in this procedural update.<\/p>
For strategic context, investors should consult prior operational announcements. The issuance and quotation of shares mark the first formal transfer of value to the vendor, with the transaction still pending completion due to the regulatory exemption condition.<\/p>
Share-Based Payment Preserves Alicanto’s Cash Reserves<\/h2>
Structuring the acquisition as a share-based transaction allows Alicanto Minerals to conserve working capital and cash for exploration and operations. This approach aligns the vendor’s interests with shareholders, as the vendor benefits only if the share price increases.<\/p>
The VWAP-based pricing for the remaining tranche ensures market alignment of the final consideration. The company did not disclose its cash or working capital position, so the precise financial impact cannot be assessed from this update.<\/p>
Regulatory Exemption for E63/1894 Key to Finalizing Transaction<\/h2>
The final A$100,000 tranche depends on a minimum expenditure exemption for E63/1894, a regulatory requirement mandating minimum exploration spend or exemption application for the 2026 year.<\/p>
If granted, Alicanto will issue shares valued at A$100,000 divided by the prevailing 10-day VWAP to the vendor. If refused, the update does not clarify the outcome for this tranche, suggesting investors seek further information from the company. The immediate market reaction to this update was not publicly available.<\/p>
Alicanto Minerals Advances Tenement Acquisition with Share Issue for E63/1894 and E63/2216<\/h2>
Alicanto Minerals Limited has progressed its acquisition of two Western Australian exploration tenements by issuing 183,231 new fully paid ordinary shares as non-cash consideration. The company’s update lodged with the ASX on 1 July 2026 confirms the shares were issued on that date, representing part of the total consideration disclosed in an Appendix 3B filed on 14 May 2026.<\/p>
The tenements involved, E63/1894 and E63/2216, are exploration licences in Western Australia. The share-based payment structure is typical in junior mining deals where conserving cash is important. By issuing shares instead of cash, Alicanto Minerals maintains liquidity while giving the vendor an interest in the company’s future performance. The update did not provide further detail on the financial terms beyond the per-share deemed value.<\/p>
Deemed Share Value of $1.3644 Reflects Non-Cash Consideration<\/h2>
The quotation application describes the 183,231 shares as "part consideration for the acquisition of E63/1894 and E63/2216," with an estimated value of $1.3644 per share. This figure represents the deemed value assigned to the shares at issuance and does not necessarily match the market trading price of AQI shares at quotation.<\/p>
While the company did not specify the total implied value of this tranche, multiplying the number of shares by the deemed price suggests a value near $250,000. Investors should note this is an approximate calculation based on disclosed data rather than a stated figure.<\/p>
Additional A$100,000 Share Tranche Dependent on Regulatory Exemption for E63/1894<\/h2>
The transaction includes a deferred component of A$100,000 in shares, contingent on E63/1894 receiving a minimum expenditure exemption from the Department of Mines, Petroleum and Exploration for the 2026 tenement year.<\/p>
The pricing of this tranche will be based on the 10-day volume-weighted average price (VWAP) of AQI shares at the time of issue, protecting both parties from short-term share price volatility and aligning the consideration with market conditions. Until the exemption is granted or denied, this portion remains outstanding and the acquisition is not fully complete. Investors should watch for updates on the exemption application.<\/p>
Total Quoted Shares Increase to 185,597,924 Following Share Issue<\/h2>
After quoting the 183,231 new shares, Alicanto Minerals’ total quoted fully paid ordinary shares rose to 185,597,924. This figure, generated by the ASX system, may not reflect the current issued capital if other related filings are in process.<\/p>
The new shares represent less than 0.1% of the total post-issue share count, indicating a minimal dilution effect. Investors should also consider the company’s broader capital structure, which includes a significant number of unquoted securities that could impact future dilution.<\/p>
Unquoted Securities Include Over 63 Million Performance Rights<\/h2>
The update reveals Alicanto Minerals holds 63,779,571 performance rights under the code AQIAAK and 1,250,000 options expiring 28 February 2028 with an exercise price of $0.696 per share, listed as AQIAAM.<\/p>
The performance rights represent a substantial potential increase in shares if vested, though the update does not detail their vesting conditions. The options allow exercise only if the AQI share price exceeds $0.696 before expiry.<\/p>
Transaction Timeline: From May 2026 Disclosure to July 2026 Share Quotation<\/h2>
The acquisition process began with an Appendix 3B lodged on 14 May 2026, indicating a proposed securities issue. The 1 July 2026 quotation application confirms the first tranche has now been issued and quoted.<\/p>
The roughly six-week period between disclosure and quotation is typical for non-cash consideration deals, which require due diligence, pricing agreement, and condition satisfaction. The timeline for the deferred tranche depends on the Department of Mines, Petroleum and Exploration’s regulatory review.<\/p>
Western Australian Tenements E63/1894 and E63/2216 Now Part of Alicanto’s Holdings<\/h2>
Tenements E63/1894 and E63/2216, located in the Kalgoorlie Minerals House administrative region, are the focus of this acquisition. Specific details on location, size, or target commodities were not provided in this procedural update.<\/p>
For strategic context, investors should consult prior operational announcements. The issuance and quotation of shares mark the first formal transfer of value to the vendor, with the transaction still pending completion due to the regulatory exemption condition.<\/p>
Share-Based Payment Preserves Alicanto’s Cash Reserves<\/h2>
Structuring the acquisition as a share-based transaction allows Alicanto Minerals to conserve working capital and cash for exploration and operations. This approach aligns the vendor’s interests with shareholders, as the vendor benefits only if the share price increases.<\/p>
The VWAP-based pricing for the remaining tranche ensures market alignment of the final consideration. The company did not disclose its cash or working capital position, so the precise financial impact cannot be assessed from this update.<\/p>
Regulatory Exemption for E63/1894 Key to Finalizing Transaction<\/h2>
The final A$100,000 tranche depends on a minimum expenditure exemption for E63/1894, a regulatory requirement mandating minimum exploration spend or exemption application for the 2026 year.<\/p>
If granted, Alicanto will issue shares valued at A$100,000 divided by the prevailing 10-day VWAP to the vendor. If refused, the update does not clarify the outcome for this tranche, suggesting investors seek further information from the company. The immediate market reaction to this update was not publicly available.<\/p>
